Search Results - Yoshimi Muta
- Showing 1 - 3 results of 3
-
1
Liver function effects of SGLT2 inhibitor and GLP‐1 receptor agonist combination treatment in patients with type 2 diabetes (post hoc analysis of RECAP study) by Daisuke Tsuriya, Kazuo Kobayashi, Kei Takeshita, Takuya Hashimoto, Moritsugu Kimura, Yoshimi Muta, Hisashi Yokomizo, Yuichi Takashi, Shunichiro Tsukamoto, Kouichi Tamura, Keizo Kanasaki, Daiji Kawanami, Masao Toyoda
Published in Journal of Diabetes Investigation (2025-07-01)Get full text
Article -
2
Association between self-stigma and diabetic complications in Japanese people with type 2 diabetes: a cross-sectional study by Asuka Kato, Yasutaka Maeda, Masae Minami, Daiji Kawanami, Mayuko Yamamoto, Yuichi Takashi, Masashi Ishizu, Kyoko Toyokawa, Dai Nagata, Kensuke Makihata, Haruki Koganemaru, Tomoki Sakamoto, Kayoko Teshima, Yuka Urata, Yoshimi Muta, Hisashi Yokomizo, Dan Sekiguchi
Published in BMJ Open (2025-06-01)Get full text
Article -
3
Influence of the combination of SGLT2 inhibitors and GLP-1 receptor agonists on eGFR decline in type 2 diabetes: post-hoc analysis of RECAP study by Yoshimi Muta, Kazuo Kobayashi, Masao Toyoda, Atsuhito Tone, Daisuke Suzuki, Daisuke Tsuriya, Hideo Machimura, Hidetoshi Shimura, Hiroshi Takeda, Hisashi Yokomizo, Kei Takeshita, Keiichi Chin, Keizo Kanasaki, Kouichi Tamura, Masaaki Miyauchi, Masuo Saburi, Miwa Morita, Miwako Yomota, Moritsugu Kimura, Nobuo Hatori, Shinichi Nakajima, Shun Ito, Shunichiro Tsukamoto, Takashi Murata, Takashi Murata, Takaya Matsushita, Takayuki Furuki, Takuya Hashimoto, Tomoya Umezono, Yuichi Takashi, Daiji Kawanami
Published in Frontiers in Pharmacology (2024-03-01)Get full text
Article